A Prescription Drug User Fee Act target date of December 10, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...
FDA assigns Prescription Drug User Fee Act (PDUFA) target date of December 10, 2025 Ayrmid Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., a cell therapy pioneer working to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback